Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05259787
Other study ID # EP hysteroscopy
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date September 28, 2022
Est. completion date December 31, 2023

Study information

Verified date November 2022
Source RenJi Hospital
Contact Jie Xiao, MD,PHD
Phone +86 13817931390
Email applexiaomz@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hysteroscopy is a gold standard method for evaluating the uterine cavity and diseases, which is gradually becoming a day-surgery in China. Propofol is one of the most commonly used intravenous anesthetics in clinic for hysteroscopic procedures, however high dose propofol bring some potential clinical safety hazards.In this study, the feasibility and safety of Etomidate combined with propofol(1:2) as improved scheme for hysteroscopic surgery will be evaluated.


Description:

Hysteroscopy is a gold standard method for evaluating the uterine cavity and diseases, which is gradually becoming a day-surgery in China. For hysteroscopic surgery using bipolar resectoscopes, hysteroscopic morcellators or shavers, it is considered efficient and safe to be performed under general anaesthesia, such as intravenous anesthesia. Propofol is one of the most commonly used intravenous anesthetics in clinic, however high dose propofol bring some potential clinical safety hazards, reducing respiratory rate and tidal volume, causing apnea or hypoxemia, and leading to hypoxia especially for obese and elderly patients. Propofol combined with etomidate as an improved scheme of intravenous anesthesia has been proved to have advantages in gastroendoscopy.In this study, the patients undergoing elective hysteroscopic surgery will be randomly assigned to two groups of intravenous anesthesia: Etomidate combined with propofol of 1:2 ratio (EP) versus Propofol (P). The sedation degree, respiratory related events (hypoxia, asphyxia incidence and maintenance time) and hemodynamic events,integrated pulmonary index (IPI) of the two groups will be evaluated to explore the feasibility and safety of the clinical application of EP mixture in hysteroscopic surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 366
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Elective hysteroscopic surgery; - intravenous anesthesia; - normal reading and understanding ability - volunteer to participate Exclusion Criteria: - serious complications such as heart failure, liver failure, pulmonary dysfunction, renal failure, etc. - predictable difficult airway - high risk of reflux aspiration - allergy to propofol or etomidate - already participated in other clinical trials within three months before admission - unwilling to cooperate

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Sedation Etomidate combined with propofol
Drug IV within 10 second during anesthesia induction.
Sedation Propofol
Drug IV within 10 second during anesthesia induction.

Locations

Country Name City State
China Ren Ji Hospital Affliated to School of Medicine, Shanghai Jiao Tong University Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
RenJi Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Modified observer's assessment of alert /sedation scores (MOAAS scores) Modified observer's assessment of alert /sedation score 0-2 as effective anesthesia for hysteroscopic procedures.The MOAAS scores is a 6-point scale that assesses the responsiveness of patients and coincides with the ASA continuum of sedation. A patient with a score of 5 responds readily to name spoken in a normal tone, 4 lethargic response to name spoken in a normal tone, 3 responds only after the name is called loudly and/or repeatedly, 2 responds only after mild prodding or shaking, 1 responds only after painful trapezius squeeze, and 0 does not respond to painful trapezius squeeze (0 to 1 deep sedation, 2 to 4 moderate sedation, and 5 minimal sedation or alert). Patients will be followed for the duration of hospital stay, an expected average of 2 hours
Primary Apnea duration The time duration from the disappearance to the recovery of spontaneous breathing, record in seconds. Patients will be followed for the duration of hospital stay, an expected average of 2 hours
Secondary Incidence of manual ventilation intervention When Pulse Oxygen Saturation(SpO2)<90% ,mask pressure ventilation or mechanical ventilation should be used as the intervention. The intervention incidence will be record in percentage. Patients will be followed for the duration of hospital stay, an expected average of 2 hours
Secondary Pulse oxygen saturation (SpO2) Pulse oxygen saturation (SpO2) will be recorded in percentage, range from 0 to 100%. Patients will be followed for the duration of hospital stay, an expected average of 2 hours
Secondary Blood Pressure(BP) Noninvasive blood pressure will be recorded in mmHg. Patients will be followed for the duration of hospital stay, an expected average of 2 hours
Secondary Heart rate (HR) Heart rate (HR) will be recorded in times/min. Patients will be followed for the duration of hospital stay, an expected average of 2 hours
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04279054 - Decreased Neuraxial Morphine After Cesarean Delivery Early Phase 1
Active, not recruiting NCT04580030 - Tricuapid Annular Plane Sistolic Excursion Before General Anesthesia Can Predict Hypotension After Induction
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Recruiting NCT04099693 - A Prospective Randomized Study of General Anesthesia Versus Anesthetist Administered Sedation for ERCP
Terminated NCT02481999 - Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years
Completed NCT04235894 - An Observer Rating Scale of Facial Expression Can Predict Dreaming in Propofol Anesthesia
Recruiting NCT05525104 - The Effect of DSA on Recovery of Anaesthesia in Children (Het Effect Van DSA op Het Herstel na Anesthesie Bij Kinderen). N/A
Recruiting NCT05024084 - Desflurane and Sevoflurane Minimal Flow Anesthesia on Recovery and Anesthetic Depth Phase 4
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03277872 - NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope N/A
Terminated NCT03940651 - Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase 4
Terminated NCT02529696 - Measuring Sedation in the Intensive Care Unit Using Wireless Accelerometers
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Terminated NCT03704285 - Development of pk/pd Model of Propofol in Patients With Severe Burns
Completed NCT02894996 - Does the Response to a Mini-fluid Challenge of 3ml/kg in 2 Minutes Predict Fluid Responsiveness for Pediatric Patient? N/A
Completed NCT05386082 - Anesthesia Core Quality Metrics Consensus Delphi Study
Terminated NCT03567928 - Laryngeal Mask in Upper Gastrointestinal Procedures N/A
Recruiting NCT06074471 - Motor Sparing Supraclavicular Block N/A
Completed NCT04163848 - CARbon Impact of aNesthesic Gas
Completed NCT03740815 - Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection N/A